Latham & Watkins LLP has advised Mineralys Therapeutics. Cleary Gottlieb has represented the underwriters, including BofA Securities Inc., Goldman Sachs & Co. LLC, and Evercore Group...
Mineralys Therapeutics Announces Royalty Repurchase, $500 Million Debt Facility, and $150 Million Equity Offering
HealthCare Royalty and Blue Owl Capital Acquire BridgeBio Pharma’s BEYONTTRA Royalty Interest for $300 Million
Gibson Dunn has advised HealthCare Royalty and Blue Owl Capital, and Latham & Watkins has advised BridgeBio Pharma. HealthCare Royalty and Blue Owl Capital have acquired...
The Container Store’s Emergence From Chapter 11
Hunton Andrews Kurth and Latham & Watkins advised The Container Store Group, Inc., while Paul Hastings advised an ad hoc group of term and DIP lenders....
Owlet’s $11.6 Million Common Stock Offering
Latham & Watkins advised Owlet in the offering, and DLA Piper advised Titan Partners Group, as underwriter. Owlet, Inc. (NYSE:OWLT), the pioneer of smart infant monitoring,...